BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
US Department of Justice

Generated: January 20, 2018

DrugPatentWatch Database Preview

Hydroxyamphetamine hydrobromide; tropicamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydroxyamphetamine hydrobromide; tropicamide and what is the scope of hydroxyamphetamine hydrobromide; tropicamide freedom to operate?

Hydroxyamphetamine hydrobromide; tropicamide
is the generic ingredient in one branded drug marketed by Akorn and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for hydroxyamphetamine hydrobromide; tropicamide. One supplier is listed for this compound.
Summary for hydroxyamphetamine hydrobromide; tropicamide
Pharmacology for hydroxyamphetamine hydrobromide; tropicamide

US Patents and Regulatory Information for hydroxyamphetamine hydrobromide; tropicamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn PAREMYD hydroxyamphetamine hydrobromide; tropicamide SOLUTION/DROPS;OPHTHALMIC 019261-001 Jan 30, 1992 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.